基本信息
views: 464
Career Trajectory
Bio
主要应用移植动物模型、基因工程改造动物及分子生物学技术,探讨T细胞移植免疫耐受及免疫应答调控的分子机制,建立移植免疫耐受的诱导方案,开发组织细胞工程产品及基因工程药物。此外,通过比较同种异种移植免疫排斥反应的异同,为寻找克服异种移植免疫排斥的有效途径提供指导。在 Nature Medicine、Nature Communications, Blood, J. Immunology、Trends in Immunology、Journal of Molecular Medicine、Immunology、Am J of Transpl 及 Transplantation 等国际刊物发表SCI学术文章130余篇,主编《异种移植免疫学》及《移植免疫耐受》。实验室目前得到科技部973项目、国家自然基金委重点项目及中科院创新方向性项目等资助。
Research Interests
Papers共 355 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Shuo Chao, Li-Jun Li, Jun Lu, Shu-Xian Zhao,Ming-Hui Zhao, Gui-An Huang,Shen Yin,Wei Shen,Qing-Yuan Sun,Yong Zhao,Zhao-Jia Ge,Lei Zhao
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapiepp.117096-117096, (2024)
Zhaoqi Zhang,Chenxu Zhao, Lingyun Sun, Chen Cheng,Qianchuan Tian,Changhong Wu,Yanan Xu,Xue Dong,Baojun Zhang,Lianfeng Zhang,Yong Zhao
EUROPEAN JOURNAL OF IMMUNOLOGYno. 3 (2024): e2350836-e2350836
Yangxiao Hou,Dong Wei,Zhaoqi Zhang,Tong Lei,Sihong Li, Jiaming Bao,Han Guo,Liang Tan,Xubiao Xie, Yuan Zhuang,Zhongbing Lu,Yong Zhao
CELL REPORTSno. 1 (2024): 113658-113658
Clinical Therapeutics (2024)
Jingyi Li,Guodong Zeng,Zezhong Zhang,Yuanli Wang, Mengyao Shao, Chunjiang Li,Zhongbing Lu,Yong Zhao,Fang Zhang,Wenjun Ding
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2024): 116162-116162
Genes & Genomicsno. 3 (2024): 303-322
EXPERT OPINION ON DRUG SAFETYpp.1-6, (2024)
International journal of molecular sciencesno. 5 (2023): 4285-4285
Luyang Cao,Lixiang Ma,Juan Zhao,Xiangyu Wang,Xinzou Fan, Wei Li,Yawen Qi,Yingkui Tang,Jieya Liu, Shengxian Peng,Li Yang,Liangxue Zhou,
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn